| [1] |
尹智明, 余朝文. 下肢动脉硬化闭塞症腔内介入治疗的研究进展[J]. 中国普通外科杂志, 2017, 26(6): 789-794.
|
| [2] |
Signorelli SS, Fiore V, Malaponte G. Inflammation and peripheral arterial disease: the value of circulating biomarkers (review)[J]. Int J Mol Med, 2014, 33(4): 777-783.
|
| [3] |
Nakazawa KR, Wengerter SP, Power JR, et al. Preoperative inflammatory status as a predictor of primary patency after femoropopliteal stent implantation[J]. J Vasc Surg, 2017, 66(1): 151-159.
|
| [4] |
Mozos I, Malainer C, Horbanczuk J, et al. Inflammatory markers for arterial stiffness in cardiovascular diseases[J]. Front Immunol, 2017, 8: 1058.
|
| [5] |
Schillinger M, Haumer M, Schlerka G, et al. Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation[J]. J Endovasc Ther, 2001, 8(5): 477-483.
|
| [6] |
Schillinger M, Exner M, Mlekusch W, et al. Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries[J]. Radiol, 2002, 224(2): 529-535.
|
| [7] |
Dai Z, Li R, Zhao N, et al. Neutrophil to lymphocyte ratio as a predictor of restenosis after angioplasty and stenting for asymptomatic carotid stenosis[J]. Angiology, 2019, 70(2): 160-165.
|
| [8] |
Davis C, Fischer J, Ley K, et al. The role of inflammation in vascular injury and repair[J]. J Thromb Haemost : JTH, 2003, 1(8): 1699-709.
|
| [9] |
Radak D, Djukic N, Tanaskovic S, et al. Should we be concerned about the inflammatory response to endovascular procedures?[J]. Curr Vasc Pharmacol, 2017, 15(3): 230-237.
|
| [10] |
Danielsson P, Truedsson L, Eriksson KF, et al. Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus[J]. Vasc Med, 2005, 10(3): 191-198.
|
| [11] |
Paquissi FC. The role of inflammation in cardiovascular diseases: the predictive value of neutrophil-lymphocyte ratio as a marker in peripheral arterial disease[J]. Ther Clin Risk Manag, 2016, 12: 851-860.
|
| [12] |
Mizzi A, Cassar K, Bowen C, et al. The progression rate of peripheral arterial disease in patients with intermittent claudication: a systematic review[J]. J Foot Ankle Res, 2019, 12: 40.
|
| [13] |
刘永东. 动脉硬化闭塞症患者早期介入治疗与机体炎症反应机制的研究进展[J]. 解放军预防医学杂志, 2018, 36(4): 540-543.
|
| [14] |
王建旗, 史旭波, 马长生, 等. 炎症预测和预防动脉粥样硬化性心血管事件的研究进展[J]. 心血管病学进展, 2018, 39(5): 687-690.
|
| [15] |
Yamashina A, Tomiyama H, Arai T, et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk[J]. Hypertens Res, 2003, 26(8): 615-622.
|
| [16] |
Isaac V, Wu CY, Huang CT, et al. Elevated neutrophil to lymphocyte ratio predicts mortality in medical inpatients with multiple chronic conditions[J]. Med, 2016, 95(23): e3832.
|
| [17] |
Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio[J]. Clin Appl Thromb-hem, 2016, 22(5): 405-411.
|
| [18] |
Park BJ, Shim JY, Lee HR, et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score[J]. Clin Chim Acta, 2011, 412(11-12): 925-929.
|
| [19] |
姜红, 吴舰, 魏光如, 等. 中性粒细胞/淋巴细胞比值与颅外颈动脉狭窄的相关性研究[J]. 中华老年心脑血管病杂志, 2016, 18(1): 55-58.
|
| [20] |
Belaj K, Pichler M, Hackl G, et al. Association of the derived neutrophil-lymphocyte ratio with critical limb ischemia[J]. Angiology, 2016, 67(4): 350-354.
|
| [21] |
Gary T, Pichler M, Belaj K, et al. Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients[J]. PloS One, 2013, 8(2): e56745.
|
| [22] |
Luo H, Yuan D, Yang H, et al. Post-treatment neutrophil-lymphocyte ratio independently predicts amputation in critical limb ischemia without operation[J]. Clinics, 2015, 70(4): 273-277.
|
| [23] |
Chang Z, Zheng J, Liu Z, et al. The Relationship between the neutrophil-lymphocyte ratio and in-stent restenosis in patients with femoropopliteal chronic total occlusions[J]. Angiology, 2018, 69(2): 177-182.
|
| [24] |
Chan C, Puckridge P, Ullah S, et al. Neutrophil-lymphocyte ratio as a prognostic marker of outcome in infrapopliteal percutaneous interventions for critical limb ischemia[J]. J Vasc Surg, 2014, 60(3): 661-668.
|
| [25] |
Endemann DH, Schiffrin EL. Endothelial dysfunction[J]. J Am Soc Nephrol, 2004, 15(8): 1983-1992.
|
| [26] |
Soehnlein O, Lindbom L, Weber C. Mechanisms underlying neutrophil-mediated monocyte recruitment[J]. Blood, 2009, 114(21): 4613-4623.
|
| [27] |
李俊超, 崔仲华. 维生素D与动脉粥样硬化相关性研究进展[J]. 中国骨质疏松杂志, 2016, 22(12): 1637-1640.
|
| [28] |
Chen C, Gu L, Chen L, et al. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential predictors of prognosis in acute ischemic stroke[J]. Front Neurol, 2020, 11: 525621.
|
| [29] |
Sharma D, Bhaskar SMM. Prognostic role of the platelet-lymphocyte ratio in acute ischemic stroke patients undergoing reperfusion therapy: a meta-analysis[J]. J Cent Nerv Syst Dis, 2022, 14: 11795735221110373.
|
| [30] |
Çiçek G, Açıkgoz SK, Bozbay M, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention[J]. Angiology, 2015, 66(5): 441-447.
|
| [31] |
Ayça B, Akin F, Okuyan E. Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention[J]. Platelets, 2015, 26(8): 816.
|
| [32] |
Ye M, Qian X, Guo X, et al. Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predict severity and prognosis of lower limb arteriosclerosis obliterans[J]. Ann Vasc Surg, 2020, 64: 221-227.
|
| [33] |
丁振, 柏霞, 梅文俊, 等. 中性粒细胞/淋巴细胞比值、血小板/淋巴细胞比值与下肢闭塞性动脉硬化患者症状严重程度和术后支架内再狭窄的关系[J]. 血管与腔内血管外科杂志, 2021, 7(3): 310-313.
|
| [34] |
Taşoğlu İ, Sert D, Colak N, et al. Neutrophil-lymphocyte ratio and the platelet-lymphocyte ratio predict the limb survival in critical limb ischemia[J]. Clin Appl Thromb-hem, 2014, 20(6): 645-650.
|
| [35] |
罗非同, 郝春艳, 滕萍萍. 淋巴细胞与动脉粥样硬化研究进展[J]. 中国药物与临床, 2015, 15(7): 960-962.
|
| [36] |
Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice[J]. J Exp Med, 2010, 207(8): 1579-1587.
|
| [37] |
Mezger M, Nording H, Sauter R, et al. Platelets and immune responses during thromboinflammation[J]. Front Immunol, 2019, 10: 1731.
|
| [38] |
Grüner S, Prostredna M, Schulte V, et al. Multiple integrin-ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo[J]. Blood, 2003, 102(12): 4021-4027.
|
| [39] |
Huang L. Increased systemic immune-inflammation index predicts disease severity and functional outcome in acute ischemic stroke patients[J]. Neurologist, 2023, 28(1): 32-38.
|
| [40] |
Weng Y, Zeng T, Huang H, et al. Systemic immune-inflammation index predicts 3-month functional outcome in acute ischemic stroke patients treated with intravenous thrombolysis[J]. Clin Interv Aging, 2021, 16: 877-886.
|
| [41] |
Yang Y, Cui T, Bai X, et al. Association between systemic immune-inflammation index and symptomatic intracranial hemorrhage in acute ischemic stroke patients undergoing endovascular treatment[J]. Curr Neurovasc Res, 2022, 19(1): 83-91.
|
| [42] |
Gong P, Liu Y, Gong Y, et al. The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke[J]. J Neuroinflammation, 2021, 18(1): 51.
|
| [43] |
Pinčáková K, Krastev G, Haring J, et al. Low lymphocyte-to-monocyte ratio as a possible predictor of an unfavourable clinical outcome in patients with acute ischemic stroke after mechanical thrombectomy[J]. Stroke Res Treat, 2022, 2022: 9243080.
|
| [44] |
Yang Y, Sun G, Diao S, et al. Diagnostic performances of neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio in acute ischemic stroke caused by cervicocranial arterial dissection[J]. J Clin Lab Anal, 2020, 34(12): e23515.
|
| [45] |
Cao X, Zhu Q, Xia X, et al. The correlation between novel peripheral blood cell ratios and 90-day mortality in patients with acute ischemic stroke[J]. PloS One, 2020, 15(8): e0238312.
|
| [46] |
Güneş M. Is neutrophil/eosinophil ratio at admission a prognostic marker for in-hospital mortality of acute ischemic stroke?[J]. J Stroke Cerebrovasc, 2020, 29(8): 104999.
|
| [47] |
Chen Y, Ren J, Yang N, et al. Eosinophil-to-monocyte ratio is a potential predictor of prognosis in acute ischemic stroke patients after intravenous thrombolysis[J]. Clin Interv Aging, 2021, 16: 853-862.
|
| [48] |
Yu S, Luo Y, Zhang T, et al. Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke[J]. BMC Neurosci, 2021, 22(1): 8.
|
| [49] |
Tuñón J, Badimón L, Bochaton-Piallat ML, et al. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology[J]. Cardiovasc Res, 2019, 115(1): 10-19.
|
| [50] |
Ridker PM, Bhatt DL, Pradhan AD, et al. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials[J]. Lancet, 2023, 401(10384): 1293-1301.
|
| [51] |
褚现明, 李冰, 安毅, 等. 炎症与动脉粥样硬化关系研究进展[J]. 中国分子心脏病学杂志, 2010, 10(3): 184-188.
|
| [52] |
Morrow DA, Lemos JA, Sabatine MS, et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial[J]. Circ, 2006, 114(4): 281-288.
|
| [53] |
Li Y, Zhou Q, Hu Z, et al. 5-aminolevulinic acid-based sonodynamic therapy induces the apoptosis of osteosarcoma in mice[J]. PloS One, 2015, 10(7): e0132074.
|
| [54] |
王巍, 程佳丽, 孙鑫, 等. 5-氨基酮戊酸介导的声动力疗法诱导巨噬细胞和泡沫细胞凋亡[J]. 中国动脉硬化杂志, 2016, 24(4): 339-344.
|
| [55] |
Sun X, Guo S, Yao J, et al. Rapid inhibition of atherosclerotic plaque progression by sonodynamic therapy[J]. Cardiovasc Res, 2019, 115(1): 190-203.
|
| [56] |
李贺, 田野, 田振. 声动力疗法引起的细胞自噬在肿瘤和动脉粥样硬化中的研究进展[J]. 基础医学与临床, 2018, 38(11): 1620-1624.
|